Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITP^2: Dexamethasone vs Prednisone in ITP
NCT00991939Phase 3Terminated
- Sponsor
- Elevance Health
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in immune thrombocytopenic purpura (ITP), sponsored by Elevance Health. Started Jan 2010; status: terminated.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00991939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00991939.